Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 168-174, February 2001

Out-of-hospital and interhospital management of crotaline snakebite☆☆

Presented at the North American Congress of Clinical Toxicology’s “Advances in the Management of Snakebite” Symposium, October 1999, La Jolla, CA.

Department of Emergency Medicine, College of Pharmacy, New Mexico Poison Center, University of New Mexico Health Sciences Center, Albuquerque, NM.

Received 1 November 1999; received in revised form 21 June 2000; accepted 28 August 2000.

Abstract 

Despite insufficient data for the development of evidence-based guidelines for the out-of-hospital treatment of crotaline snake envenomation, practical concerns dictate a rational approach based on existing information. Out-of-hospital care should focus on stabilization and rapid transport of the victim to a health care facility with the capability of antivenom administration. However, the out-of-hospital interval provides for the evaluation and management of the patients with snakebite. Out-of-hospital providers must be familiar with common first-aid techniques and be aware of their potential complications. Proven measures to slow systemic absorption are limited but should include immobilization of the bitten extremity in a neutral position in every case, and the patient should maintain strict bed rest. Constriction bands or pressure wraps placed on the wound at the scene and without vascular compromise should be left in place until arrival at a health care facility. Placement of a constriction band or pressure wrap (to delay systemic absorption of venom) can be considered for prolonged transport times or when the patient’s condition is deteriorating. A suction device, if applied and functioning, should be left in place. Vital signs should be closely monitored to assess for hypotension as a sign of systemic toxicity. The extent of local swelling should be documented, and information regarding extent and progression of the envenomation syndrome should be relayed to the receiving hospital to expedite antivenom administration, if indicated. During interhospital transport of patients who have received or continue to receive antivenom, the patient should be monitored for allergic reactions to treatment and treated appropriately. Routine stocking of the existing horse serum antivenom product on ambulances is not recommended because of the extended length of time required to prepare the infusion and potential allergic complications. Antivenoms with improved side effect profiles may be better suited to use in the out-of-hospital setting in well-defined cases. [McKinney PE. Out-of-hospital and interhospital management of crotaline snakebite. Ann Emerg Med. February 2001;37:168-174.]

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by a grant from Savage Laboratories, Melville, NY.

☆☆ Address for reprints: Patrick McKinney, MD, Department of Emergency Medicine, 4th Floor, Ambulatory Care Center, University of New Mexico Health Sciences Center, Albuquerque NM 87131; 505-272-5062, fax 505-272-6503;,E-mail patmckin@unm.edu .

PII: S0196-0644(01)88118-X

doi:10.1067/mem.2001.111574

Refers to article:

  • Role of surgical intervention in the management of crotaline snake envenomation

    Edward L. Hall
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 175-180)

  • Efficacy, safety, and use of snake antivenoms in the United States

    Richard C. Dart, Jude McNally
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 181-188)

  • Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies

    Steven A. Seifert, Leslie V. Boyer
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 189-195)

  • Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline fab antivenom

    Leslie V. Boyer, Steven A. Seifert, Jeffrey S. Cain
    Annals of Emergency Medicine February 2001 (Vol. 37, Issue 2, Pages 196-201)

Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 168-174, February 2001